Topics
Glioblastoma | Treatment | Radiotherapy | Margins
Home > Publications > Topics > Glioblastoma > Treatment > Radiotherapy > Margins
Di
Perri D, Hofstede D, Hartgerink D, Terhaag K, Houben R, Postma AA,
Hoeben A, Anten M, Ackermans L, Compter I, Eekers DBP.
Impact
of clinical target volume margin reduction in glioblastoma
patients treated with concurrent chemoradiation.
Neurooncol
Pract.
2023 Oct 27;11(3):249-254. doi:
10.1093/nop/npad071. PMID:
38737612. Observational study. ˍ
Yilmaz MT, Kahvecioglu A, Yedekci FY, Yigit E, Ciftci GC, Kertmen
N, Zorlu F, Yazici G.
Comparison of
different target volume delineation strategies based on recurrence
patterns in adjuvant radiotherapy for glioblastoma.
Neurooncol
Pract. 2024 Jan 31;11(3):275-283. doi:
10.1093/nop/npae009. PMID:
38737611. Observational
study. ˍ
Holzgreve
A, Nitschmann A, Maier SH, Büttner M, Schönecker S,
Marschner SN, Fleischmann DF, Corradini S, Belka C, la Fougère
C, Bodensohn R, Albert NL, Niyazi M.
FET
PET-based target volume delineation for the radiotherapy of
glioblastoma: A pictorial guide to help overcome methodological
pitfalls.
Radiother
Oncol.
2024 Jun 14:110386. doi:
10.1016/j.radonc.2024.110386. PMID:
38880414. Guidelines. ˍ
Ferini G, Scalia G, Harikar M, Zagardo V, Castorina L, Comis A,
Boncoraglio A, Chaurasia B, Palmisciano P, Umana GE.
Comparative
Analysis of Recurrent Glioblastoma Target Contours via
11C-Methionine,
68Ga-Prostate-Specific
Membrane Antigen Positron Emission Tomography, and Magnetic
Resonance Imaging: Implications for Precision Radiotherapy
Planning.
Adv
Radiat Oncol. 2024 Jun 4;9(9):101548. doi:
10.1016/j.adro.2024.101548. PMID:
39188994. Case report. ˍ
Tang PLY, Romero AM, Nout RA, van Rij C, Slagter C, Swaak-Kragten
AT, Smits M, Warnert EAH.
Amide proton
transfer-weighted CEST MRI for radiotherapy target
delineation of glioblastoma: a
prospective pilot study.
Eur
Radiol Exp. 2024 Oct 30;8(1):123. doi:
10.1186/s41747-024-00523-4. PMID:
39477835. Interventional study. ˍ